- Home
- SD vs CYRX Comparison
SD vs CYRX Comparison
Compare SD & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SD
- CYRX
- Stock Information
- Founded
- SD 2006
- CYRX 1999
- Country
- SD United States
- CYRX United States
- Employees
- SD N/A
- CYRX N/A
- Industry
- SD Oil & Gas Production
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- SD Energy
- CYRX Health Care
- Exchange
- SD Nasdaq
- CYRX Nasdaq
- Market Cap
- SD 465.2M
- CYRX 422.6M
- IPO Year
- SD 2007
- CYRX N/A
- Fundamental
- Price
- SD $11.19
- CYRX $6.15
- Analyst Decision
- SD
- CYRX Buy
- Analyst Count
- SD 0
- CYRX 7
- Target Price
- SD N/A
- CYRX $13.14
- AVG Volume (30 Days)
- SD 303.1K
- CYRX 533.2K
- Earning Date
- SD 03-10-2025
- CYRX 03-04-2025
- Dividend Yield
- SD 3.80%
- CYRX N/A
- EPS Growth
- SD 3.05
- CYRX N/A
- EPS
- SD 1.69
- CYRX N/A
- Revenue
- SD $125,290,000.00
- CYRX $228,385,000.00
- Revenue This Year
- SD $57.83
- CYRX $9.31
- Revenue Next Year
- SD N/A
- CYRX $8.36
- P/E Ratio
- SD $6.86
- CYRX N/A
- Revenue Growth
- SD N/A
- CYRX N/A
- 52 Week Low
- SD $10.31
- CYRX $4.58
- 52 Week High
- SD $15.31
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- SD 49.53
- CYRX 53.83
- Support Level
- SD $10.74
- CYRX $4.65
- Resistance Level
- SD $11.50
- CYRX $6.74
- Average True Range (ATR)
- SD 0.41
- CYRX 0.75
- MACD
- SD -0.04
- CYRX 0.18
- Stochastic Oscillator
- SD 48.93
- CYRX 92.48
About SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.